Solstice Achieves 400M TVL Milestone as NYSEListed Bullish Joins Institutional Allocator Network Private Payrolls Rise 109000 in April Surpassing Expectations ADP Report Brainbees Solutions Narrows Q4 Loss as Firstcry Parent Reports 12 Revenue Growth Indias Five Listed REITs Distribute Over Rs 8900 Crore in FY26 AI Demand Drives Supply Constraints for Lasers Fiber Optics and Optical Components Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Evolving Cybersecurity Demand Trends Omega Healthcare Investors Inc OHI Q1 2026 Earnings Solid EPS Beat Fails to Lift Stock Western Midstream Partners Q1 2026 Earnings EPS Beats Estimates by 1391 Stock Rises CINT Q1 2026 Earnings EPS Misses Estimates Stock Rises on Optimism Ameren Corporation AEE Q1 2026 Earnings EPS Surges Past Expectations as Utility Operations Drive Steady Performance ELS Q1 2026 Earnings Modest EPS Beat and Steady Market Response Versus Systems Inc Q4 2025 Earnings Continued Losses Amid Restructuring Efforts Axiom Intelligence Acquisition Corp AXIN Holds Steady at 1022 as SPAC Consolidation Continues XORTX Therapeutics XRTX Gains 127 as Shares Test Key Resistance Level Workiva Inc WK Declines 195 as Stock Tests Critical Support Level Hawaiian Electric HE Slips 073 as Utility Sector Pressure Persists Stem Inc STEM Slips 146 Amid Resistance Test Key Support at 96 in Focus Cruz and Cantwells Potential College Football Legislation Raises Industry Concerns NetScout Systems NTCT Q1 2026 Earnings EPS Surpasses Estimates Amid Margin Discipline Climb Bio Inc CLYM Edges Higher Navigating Support and Resistance Levels Park Aerospace Corp PKE Slides 231 as Support Level Nears Karyopharm Therapeutics KPTI Edges Higher as Volume Picks Up Key Resistance Level Ahead Alphabet Inc GOOG Nears Resistance as Modest Gains Signal Consolidation Adamas Trust Inc ADAM Holds Steady Near Support in LowVolume Trading Phathom Pharmaceuticals PHAT Slips 216 as Stock Tests Key Support Levels Oaktree Specialty Lending Corporation OCSL Edges Higher as Support Holds Steady Ekso Bionics EKSO Climbs 129 as Stock Tests Key Resistance Level